Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G David Roodman

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Annals of the New York Academy of Sciences|April 16, 2010
Insights into the pathogenesis of Paget's diseaseG David Roodman
Cell Metabolism|May 7, 2009
Osteoclasts pump ironG David Roodman
Current Opinion in Supportive and Palliative Care|July 20, 2011
Bone effects of cancer therapies: pros and consRebecca Silbermann, G David Roodman
Future Oncology (London, England)|June 22, 2006
Role of the microenvironment in multiple myeloma bone diseaseAlissa Huston, G David Roodman
Bonekey Reports|November 6, 2015
Mechanisms of osteolytic and osteoblastic skeletal lesionsG David Roodman, Rebecca Silbermann
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Advances in the biology and treatment of bone disease in multiple myelomaNoopur Raje, G David Roodman
Cold Spring Harbor Perspectives in Medicine|December 13, 2017
Multiple Myeloma and Bone: The Fatal InteractionSilvia Marino, G David Roodman
Current Hematologic Malignancy Reports|April 29, 2010
The role of bisphosphonates in multiple myelomaJessica Levy, G David Roodman
Journal of Bone Oncology|February 25, 2016
Myeloma bone disease: Pathophysiology and managementRebecca Silbermann, G David Roodman
The Journal of Clinical Investigation|February 4, 2005
Paget disease of boneG David Roodman, Jolene J Windle
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Annals of the New York Academy of Sciences|April 16, 2010
Insights into the pathogenesis of Paget's diseaseG David Roodman
Cell Metabolism|May 7, 2009
Osteoclasts pump ironG David Roodman
Current Opinion in Supportive and Palliative Care|July 20, 2011
Bone effects of cancer therapies: pros and consRebecca Silbermann, G David Roodman
Future Oncology (London, England)|June 22, 2006
Role of the microenvironment in multiple myeloma bone diseaseAlissa Huston, G David Roodman
Bonekey Reports|November 6, 2015
Mechanisms of osteolytic and osteoblastic skeletal lesionsG David Roodman, Rebecca Silbermann
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Advances in the biology and treatment of bone disease in multiple myelomaNoopur Raje, G David Roodman
Cold Spring Harbor Perspectives in Medicine|December 13, 2017
Multiple Myeloma and Bone: The Fatal InteractionSilvia Marino, G David Roodman
Current Hematologic Malignancy Reports|April 29, 2010
The role of bisphosphonates in multiple myelomaJessica Levy, G David Roodman
Journal of Bone Oncology|February 25, 2016
Myeloma bone disease: Pathophysiology and managementRebecca Silbermann, G David Roodman
The Journal of Clinical Investigation|February 4, 2005
Paget disease of boneG David Roodman, Jolene J Windle
Pageof 15